loadpatents
name:-0.010423183441162
name:-0.0097429752349854
name:-0.0037128925323486
COHEN; Pinchas Patent Filings

COHEN; Pinchas

Patent Applications and Registrations

Patent applications and USPTO patent grants for COHEN; Pinchas.The latest application filed is for "mentsh analogs as therapeutics for diabetes, obesity, and their associated diseases and complications".

Company Profile
2.9.16
  • COHEN; Pinchas - Los Angeles CA
  • Cohen; Pinchas - Pacific Palisades CA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Mentsh Analogs As Therapeutics For Diabetes, Obesity, And Their Associated Diseases And Complications
App 20210371479 - COHEN; Pinchas ;   et al.
2021-12-02
Insulin-like Growth Factor-1 Receptor (igf-1r) Binding Proteins And Methods Of Use
App 20210332141 - Beltran; Pedro ;   et al.
2021-10-28
MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications
Grant 11,124,551 - Cohen , et al. September 21, 2
2021-09-21
Mitochondrial-derived peptide MOTS3 regulates metabolism and cell survival
Grant 10,391,143 - Cohen , et al. A
2019-08-27
Mentsh Analogs As Therapeutics For Diabetes, Obesity, And Their Associated Diseases And Complications
App 20190194275 - Cohen; Pinchas ;   et al.
2019-06-27
Mitochondrial-derived Peptide Mots3 Regulates Metabolism And Cell Survival
App 20180360910 - Cohen; Pinchas ;   et al.
2018-12-20
Mitochondrial-derived peptide MOTS3 regulates metabolism and cell survival
Grant 10,064,914 - Cohen , et al. September 4, 2
2018-09-04
Mitochondrial-derived Peptide Mots3 Regulates Metabolism And Cell Survival
App 20170049853 - COHEN; Pinchas ;   et al.
2017-02-23
Mitochondrial-derived Peptide Mots3 Regulates Metabolism And Cell Survival
App 20140296139 - COHEN; Pinchas ;   et al.
2014-10-02
Small Humanin-like Peptides
App 20140213527 - COHEN; Pinchas ;   et al.
2014-07-31
Method of treatment of type-1 diabetes with humanin analogues
Grant 8,653,027 - Cohen , et al. February 18, 2
2014-02-18
Small humanin-like peptides
Grant 8,637,470 - Cohen , et al. January 28, 2
2014-01-28
Humanin And Humanin-analogues For The Management Of Atherosclerosis
App 20130123168 - Cohen; Pinchas ;   et al.
2013-05-16
Treatment Of Type 2 Diabetes, Metabolic Syndrome, Myocardial Injury And Neurodegeneration With Humanin And Analogs Thereof
App 20130045916 - Barzilai; Nir ;   et al.
2013-02-21
Treatment of type 2 diabetes, metabolic syndrome, myocardial injury and neurodegeneration with humanin and analogs thereof
Grant 8,309,525 - Barzilai , et al. November 13, 2
2012-11-13
Compositions To Prevent And Treat Type-1 Diabetes
App 20120021981 - COHEN; PINCHAS ;   et al.
2012-01-26
Method of treatment of type-1 diabetes with a humanin analogue
Grant 7,998,928 - Cohen , et al. August 16, 2
2011-08-16
Small Humanin-like Peptides
App 20110039771 - Cohen; Pinchas ;   et al.
2011-02-17
Treatment Of Type 2 Diabetes, Metabolic Syndrome, Myocardial Injury And Neurodegeneration With Humanin And Analogs Thereof
App 20100204099 - Barzilai; Nir ;   et al.
2010-08-12
Compositions to prevent and treat type-1 diabetes
App 20100130412 - Cohen; Pinchas ;   et al.
2010-05-27
Company Registrations
NCAGE Code48KL3COHEN PINCHAS
CAGE Code48KL3COHEN, PINCHAS
SEC0001628471Cohen Pinchas
SEC0001333697Cohen Pinchas

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed